SLC22A17
Solute carrier family 22 member 17
Also known as: BOCT, BOIT, NGALR, S22AH_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8WUG5
- Gene
- SLC22A17
- Ensembl
- ENSG00000092096
- Chromosome
- 14
- Canonical length
- 649 aa
- Protein class
- Predicted membrane proteins, Transporters
OverviewNCBI Gene
Predicted to enable transmembrane signaling receptor activity. Predicted to be involved in siderophore transport. Located in organelle membrane and plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
649 residues, UniProt reviewed canonical sequence.
>Q8WUG5|SLC22A17
1 MAPRVATGTP EPNGGGGGKI DNTVEITPTS NGQVGTLGDA VPTEQLQGER EREREGEGDA
61 GGDGLGSSLS LAVPPGPLSF EALLAQVGAL GGGQQLQLGL CCLPVLFVAL GMASDPIFTL
121 APPLHCHYGA FPPNASGWEQ PPNASGVSVA SAALAASAAS RVATSTDPSC SGFAPPDFNH
181 CLKDWDYNGL PVLTTNAIGQ WDLVCDLGWQ VILEQILFIL GFASGYLFLG YPADRFGRRG
241 IVLLTLGLVG PCGVGGAAAG SSTGVMALRF LLGFLLAGVD LGVYLMRLEL CDPTQRLRVA
301 LAGELVGVGG HFLFLGLALV SKDWRFLQRM ITAPCILFLF YGWPGLFLES ARWLIVKRQI
361 EEAQSVLRIL AERNRPHGQM LGEEAQEALQ DLENTCPLPA TSSFSFASLL NYRNIWKNLL
421 ILGFTNFIAH AIRHCYQPVG GGGSPSDFYL CSLLASGTAA LACVFLGVTV DRFGRRGILL
481 LSMTLTGIAS LVLLGLWDCE HPIFPTVWAQ QGNPNRDLNE AAITTFSVLG LFSSQAAAIL
541 STLLAAEVIP TTVRGRGLGL IMALGALGGL SGPAQRLHMG HGAFLQHVVL AACALLCILS
601 IMLLPETKRK LLPEVLRDGE LCRRPSLLRQ PPPTRCDHVP LLATPNPALLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SLC22A17 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 11
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 277 nTPM
Expression across tissuesHPA
Tissue
- hypothalamus: 277 nTPM
- basal ganglia: 248 nTPM
- cerebral cortex: 236 nTPM
- choroid plexus: 235 nTPM
- cerebellum: 188 nTPM
- pituitary gland: 178 nTPM
Single-cell type
- other brain neurons: 280 nCPM
- pancreatic islet cells: 210 nCPM
- oligodendrocyte progenitor cells: 178 nCPM
- brain inhibitory neurons: 171 nCPM
- prostatic glandular cells: 169 nCPM
- corticotrophs: 160 nCPM
Immune cell
- naive CD4 T-cell: 0.7 nTPM
- memory CD4 T-cell: 0.3 nTPM
- naive CD8 T-cell: 0.2 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
Brain region
- choroid plexus: 872 nTPM
- hypothalamus: 732 nTPM
- basal ganglia: 437 nTPM
- cerebral cortex: 434 nTPM
- medulla oblongata: 428 nTPM
- midbrain: 409 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.58
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 1.42
- DepMap mean gene effect
- -0.21
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SLC22A17 as an antibody target. Whether an autoantibody or antibody against SLC22A17 could matter depends on whether native SLC22A17 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SLC22A17 is annotated at the cell surface, where native SLC22A17 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SLC22A17 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...